Objective: Bakumondo-to (Mai men long tang, B), a traditional Chinese blended medicine, has notable antitussive activity in bronchitic guinea-pigs. In this study, we examined whether or not B was effective in treating postinfectious cough.
INTRODUCTION
Cough is a problem in that physicians frequently encounter in clinical situations.1) It is treated by identifying the cause and administering appropriate medicine.2)3) Major causes of chronic, persistent coughing that continues for more than three weeks despite normal chest X-ray (CXR) and respiratory functions are postnasal drip, cough-variant asthma, and gastroesophageal reflux induced cough.2)3) Postinfectious (persistent) cough is also reported to be one of the causes.3) There is an increasing usage of Chinese traditional medicines in hospitals, because such medicines tend to have minor side effects coupled with at times, a remarkable efficacy. Fuchikami et al. reported that Bakumondo-to (Mai men long tang), a traditional Chinese blended medicine had notable antitussive activity produced by a peripheral mechanism of action on the cough associated with bronchitic guinea-pigs.4) We have reported earlier that Bakumondo -to was effective in treating postinfectious persistent cough.5)6) In a comparative study of cough disappearance rates one week after the administration of a variety of drugs, we found that the rates were 0 % for the nine patients given only dextromethorphan hydrobromide (a central non-narcotic antitussives), 18%
for the eleven patients given a combination of dextromethorphan and oxatomide, a H1 receptor antagonist, and 50% for the eighteen patients given those two drugs plus Bakumondo-to.7)8)These findings showed that, for patients with postinfectious persistent cough, the cough-disappearance rate was highest in the group receiving a combination of three drugs including Bakumondo-to. For this study, we compared the antitussive effects of Bakumondo-to and dextromethorphan on postinfectious cough.
MATERIALS AND METHODS

Definition of postinfectious cough
Postinfectious cough was defined as a symptom meeting the following five requirements: (1) cough (primarily dry cough) which follows cold-like symptoms, including nasal secretion, sneezing, nasal obstruction, fever, epiphora, sore throat, and hoarseness; (2) this cough persists for more than two weeks; (3) the patient has no history of nasal and/or paranasal disease and chronic pulmonary disease which may cause cough; (4) the patient has no history of atopy, does not use angiotensin-converting enzyme (ACE) inhibitors orally, and does not have bronchial asthma, gastroesophageal reflux, postnasal drip, chronic obstructive pulmonary disease, or pneumonia; and (5) 
Methods
Protocol
We interviewed the subjects and confirmed that they did not take ACE inhibitors orally, did not smoke, and had no history of nasal and/or paranasal disease, chronic pulmonary disease or gastroesophageal reflux disease. Moreover, we conducted physical examinations to confirm that they had no postnasal drip and that there were no abnormal findings on chest auscultation. We then conducted CXR and pulmonary function tests to confirm that there were no abnormalities. We also checked to see if there were no abnormalities in peripheral leukocyte counts, peripheral eosinophil counts, CRP concentrations, and serum IgE concentrations. Furthermore, only those patients who were able to maintain a cough diary were considered competent subjects.
Subjects were divided randomly into two groups:
those given a daily dose of 9g of Bakumondo-to extract granules (Tsumura Corp; Tokyo, Japan) orally, and those given a daily dose of 60mg of dextromethorphan orally. Patients in both groups took the drugs orally for one week. Using a cough diary, we compared and studied the antitussive effects between the two groups. Specifically, we compared and studied the cough scores for the day immediately before therapy, the day of therapy (the first day), the second, third, fourth, fifth, sixth, and seventh days of therapy, respectively.
Assessment of cough (cough diary)8)
The degree of cough (frequency and intensity) was divided into four levels: zero for no cough, 1 for mild coughing, 2 for strong coughing, and 3 for extremely strong coughing. We also divided the day into the following three time zones: morning to af- and record the scores. Thus, a daily total cough score ranged from 0 to 9 points.
Assessment of adverse reactions
During examination one week after administration, we asked the patients about adverse reactions.
Statistical processing
Mann-Whitney U-test (Table 1) , one-way repeated -measures ANOVA ( Fig.1 and 2 ) and two-way repeated-measures ANOVA (Fig.3) were used to test for statistical significance, with P < 0.05 deemed to be significant. In addition, 7 tests (1 test for each day) were carried out for each group, the significance level was corrected with the Bonferroni inequality method. Thus, when the probability was smaller than the significance level of al 7, we expressed it as P< a, by setting a=0.05.
RESULTS
Interim analysis was made after thirteen patients each were registered in both groups. These 26 patients all met the diagnostic criteria for postinfectious cough, and had their peripheral leukocyte/eosinophil counts, CRP concentrations, and serum IgE concentrations within the normal range.
One dextromethorphan group patient dropped out because of failure to bring a cough diary when visiting the hospital. Other patients kept their cough diaries on a regular basis. Table 1 shows the comparison of background factors between the thirteen patients in the Bakumondo-to group (one male and twelve females) and the twelve patients in the dextromethorphan group (one male and eleven females). There were no significant differences between the two groups in terms of age, sex, cough duration, test findings, and cough scores one day before treatment. Moreover, cough scores fell significantly on the third, sixth and seventh day. There were no serious adverse reactions. Fig. 3 shows the changes in post-treatment% cough scores for both groups, with the cough scores of the day immediately before treatment assigned a used guinea-pigs which had become bronchitic after inhaling sulfur dioxide gas, and reported that: (1) Bakumondo-to suppressed the cough which had increased after inhaling substance P and phosphoramidon (neutral endopeptidase inhibitor), and (2) Until now, no standard method has been established to evaluate cough. A variety of methods are currently being tested, such as using cough diaries as a subjective assessment method, and inducing cough by inhaling distilled water, capsaicin and tartaric acid, as an objective method. For this study, we utilized a subjective assessment method using cough diaries.
Cough is one of the five symptoms of which outpatients complain the most frequently.20' Establishment of a standard method to assess cough, and a standard method to treat postinfectious cough is strongly called for.
In conclusion, we studied the antitussive effects of Bakumondo-to and dextromethorphan hydrobromide for postinfectious cough, using cough diaries. Significant antitussive effects were seen in both groups. But cough scores dropped significantly from the second day for Bakumondo-to, and on the third, sixth and seventh day for dextromethorphan. Bakumondo-to was thought to demonstrate antitussive effects more rapidly after administration compared to dextromethorphan. We hope to undertake a cooperative randomized double blind trial in patients with postinfectious cough to further evaluate the efficacy of Bakumondo-to compared to oral or inhaled steroids, or inhaled ipratropium.
